| (CHF) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 77.19M | 97.40% |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SANN.SW returned +10.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +26.8% |
| 1 year | +10.4% |
| 5 years | -29.8% |
| 10 years | -96.9% |
| All-time high | CHF 1,170.00 (May 2007) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what CHF1,000 in SANN.SW would be worth today ›No. Santhera Pharmaceuticals Holding AG has not paid a dividend in the past 12 months.
Santhera Pharmaceuticals Holding AG is part of the Healthcare sector.
Santhera Pharmaceuticals Holding AG has a market cap of 243.63M CHF, based on the latest quote.
